Abstract: Disclosed are a near-infrared absorbing composition including a copper complex represented by Chemical Formula 1, a near-infrared absorption layer formed by using the near-infrared absorbing composition including the copper complex represented by Chemical Formula 1, an optical structure including the near-infrared absorption layer, and a camera module or an electronic device including the optical structure, wherein Chemical Formula 1 is provided below, and and in Chemical Formula 1, R1, R2, x, and y are the same as described in the detailed description.

Abstract: An optical filter includes a light absorbing layer and a conductive nanodisk. The light absorbing layer includes a near-infrared absorbing material configured to absorb light of a first wavelength spectrum within a near-infrared wavelength spectrum. The conductive nanodisk is configured to absorb or reflect light of a second wavelength spectrum within the first wavelength spectrum. An image sensor includes the optical filter, a camera module includes the optical filter, and an electronic device includes the optical filter.

Abstract: Disclosed are a combination structure including a nanostructure array including a plurality of nanostructures with a smaller dimension than the near-infrared wavelength are repeatedly arranged and a light absorption portion adjacent to the nanostructure array and including a near-infrared absorbing material configured to absorb light in at least a portion of near-infrared wavelength regions, an optical filter, an image sensor, a camera module, and an electronic device including the same.

Abstract: Disclosed are a compound represented by Chemical Formula 1, an optical filter, an image sensor, a camera module, and an electronic device. In Chemical Formula 1, R1 to R27 and n are the same as defined in the detailed description.

Abstract: Disclosed are an optical structure, and a camera module and an electronic device including the same. The optical structure includes a transparent substrate; a first moisture-proof layer disposed on the transparent substrate and including a first organic material having moisture-proof properties; and a first near-infrared absorbing layer disposed between the transparent substrate and the first moisture-proof layer and including a copper complex, wherein the first organic material having moisture-proof properties has a water vapor transmission rate (WVTR) of less than or equal to about 100 g/m2/day measured at a thickness of 100 ?m.

Abstract: Disclosed are a near-infrared absorbing composition, an optical structure, and a camera module and an electronic device including the same. The near-infrared absorbing composition includes a copper complex represented by Chemical Formula 1. Definitions of Chemical Formula 1 are the same as described in the detailed description.

Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.

Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.

Abstract: Disclosed are a near-infrared absorbing composition, an optical structure, and a camera module and an electronic device including the same. The near-infrared absorbing composition includes a copper complex represented by Chemical Formula 1. Definitions of Chemical Formula 1 are the same as described in the detailed description.

Abstract: Disclosed are a near-infrared absorbing composition, an optical structure, and a camera module and an electronic device including the same. The near-infrared absorbing composition includes a copper complex represented by Chemical Formula 1. (L1)-Cu-(L2)n ??[Chemical Formula 1] Definitions of Chemical Formula 1 are described in the detailed description.

Abstract: A walking assistance device includes: an upper body disposed on a thigh of a user; a lower outer body rotatably connected to the upper body and disposed on a calf of the user; a lower inner body disposed to at least partially overlap the lower outer body; a first elastic portion which has a bent part in contact with the ground so as to provide an elastic force during a user's walk; an Achilles tendon portion connected to one end of the first elastic portion and slidably connected to the lower outer body and the lower inner body; a second elastic portion interposed between the upper body and the lower outer body; and a loading potion which is connected to a bent part of the second elastic portion and movably installed in the lower outer body.

Abstract: A nano-structured block copolymer that includes a self-assembled block copolymer disposed on a substrate, wherein the block copolymer includes a plurality of block structural units, and at least two block structural units have a solubility parameter difference of greater than or equal to about 5 megaPascal1/2.

Abstract: The present invention relates to a composition for preventing or treating dry eye syndrome or eye diseases caused by dry dyes, containing imatinib as an active ingredient and, more specifically, to an eye bath lotion for preventing or treating dry eye syndrome or eye diseases associated with dry eye syndrome, containing imatinib an active ingredient. Imatinib of the present invention effectively protects the corneal epithelia and inhibits the degeneration thereof, thereby being usable for a use of alleviating or treating dry eye syndrome or eye diseases associated with dry eye syndrome.

Abstract: An electrical conductor includes a substrate; and a conductive layer disposed on the substrate and including a plurality of silver nanowires, wherein the silver nanowires exhibit a main peak assigned to a (111) crystal plane in an X-ray diffraction spectrum thereof, and a 2? full width at half maximum (FWHM) of the main peak after Gaussian fitting is less than about 0.40 degrees.

Abstract: The present invention relates to a composition for preventing or treating dry eye syndrome or eye diseases caused by dry dyes, containing imatinib as an active ingredient and, more specifically, to an eye bath lotion for preventing or treating dry eye syndrome or eye diseases associated with dry eye syndrome, containing imatinib an active ingredient. Imatinib of the present invention effectively protects the corneal epithelia and inhibits the degeneration thereof, thereby being usable for a use of alleviating or treating dry eye syndrome or eye diseases associated with dry eye syndrome.

Abstract: A polymer having a repeating unit represented by Formula 1, wherein R1 through R14, X1, and Ar1 are the same as defined in the detailed description, and an organic light-emitting diode including the polymer are described.

Abstract: A conductor includes a substrate, a first conductive layer disposed on the substrate and including two or more islands including graphene, and a second conductive layer disposed on the first conductive layer and including a conductive metal nanowire, wherein at least one of an upper surface and a lower surface of the islands including graphene includes a P-type dopant.

Abstract: A conductor includes a substrate, a first conductive layer disposed on the substrate and including two or more islands including graphene, and a second conductive layer disposed on the first conductive layer and including a conductive metal nanowire, wherein at least one of an upper surface and a lower surface of the islands including graphene includes a P-type dopant.

Abstract: An electrical conductor includes a substrate; and a conductive layer disposed on the substrate and including a plurality of silver nanowires, wherein the silver nanowires exhibit a main peak assigned to a (111) crystal plane in an X-ray diffraction spectrum thereof, and a 2? full width at half maximum (FWHM) of the main peak after Gaussian fitting is less than about 0.40 degrees.

Abstract: The present invention relates to guanidine compounds for inhibiting mitochondrial oxidative phosphorylation (OXPHOS) and use thereof. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating a OXPHOS-related disease, particularly cancer, by inhibiting mitochondrial oxidative phosphorylation and reprogramming cellular metabolism.